Abstract
Background Adult residential and nursing care homes are settings in which older and often vulnerable people live in close proximity. This population experiences a higher proportion of respiratory and gastrointestinal illnesses than the general population and has been shown to have a high morbidity and mortality in relation to COVID-19.
Methods We examined 3,115 hospital discharges to 1,068 Welsh adult care homes and the subsequent outbreaks of COVID-19 occurring over an 18 week period between 22 February and 27 June 2020. A Cox proportional hazards regression model was used to assess the impact of time-dependent exposure to hospital discharge on the incidence of the first known outbreak, over a window of 7-21 days after discharge, and adjusted for care home characteristics, including size, type of provision and health board.
Results A total of 330 homes experienced an outbreak of COVID-19, and 544 homes received a discharge from hospital over the study period. The exposure to discharge from hospital was not associated with a significant increase in the risk of a new outbreak (hazard ratio 1·15, 95% CI 0·89, 1·47, p = 0·29) after adjusting for care home characteristics. Care home size was by far the most significant predictor. Hazard ratios (95% CI) in comparison to homes of <10 residents were: 3·40 (1·99, 5·80) for 10-24 residents; 8·25 (4·93, 13·81) for 25-49 residents; and 17·35 (9·65, 31·19) for homes of 50+ residents. When stratified for care home size, the outbreak rates were similar for periods when homes were exposed to a hospital discharge, in comparison to periods when homes were unexposed.
Conclusion Our analyses showed that large homes were at considerably greater risk of outbreaks throughout the epidemic, and after adjusting for care home size, a discharge from hospital was not associated with a significant increase in risk.
What is already known on this subject
Care home populations experience more respiratory outbreaks than the general population1 and older people have been more severely affected by COVID-19, with a case fatality proportion of 2·3% overall but 8% in those aged 70-79 and 14·8% in those aged over 802
Evidence and modelling suggested that up to half of all COVID-19 fatalities could come from the care home population3 and that testing prior to hospital discharge was not always available or undertaken9
Type and use of PPE6 and the number of staff employed can have an impact on care home outbreaks of COVID-196,7
What this study adds
Our analysis found no effect of hospital discharges on care home outbreaks once care home size had been adjusted for. In line with previous studies, larger care homes were much more likely to experience an outbreak
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was undertaken as part of Public Health Wales's COVID-19 response, in partnership with Swansea University and cooperation from the seven Welsh Health Boards and Care Inspectorate Wales. No specific funding was requested or granted for the undertaking of this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Ethical oversight of the project was provided by PHW R&D Division. As this work was carried out as part of the health protection response to a public health emergency in Wales, using routinely collected surveillance data, PHW R&D Division advised that NHS research ethics approval was not required. The use of named patient data in the investigation of communicable disease outbreaks and surveillance of notifiable disease is permitted under Public Health Wales Establishment Order. Data were held and processed under Public Health Wales information governance arrangements, in compliance with the Data Protection Act, Caldicott Principles and Public Health Wales guidance on the release of small numbers. No data identifying protected characteristics of an individual were released outside Public Health Wales.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Datasets included patient identifiable information. These were cleaned and anonymised before performing analysis on them. The anonymised data used for analysis is held on Public Health Wales servers and could be provided in principle to third parties.
